MGI Tech
Providing real-time, comprehensive, life-long solutions, its mission is to advance life science tools and lead digital health innovation.
| Date | Investors | Amount | Round |
|---|---|---|---|
$200m Valuation: $800m | Series A | ||
* | N/A | Series B | |
$1.0b | Series B | ||
| Total Funding | $1.2b | ||
Related Content
MGI Tech, a subsidiary of the BGI Group, specializes in the development and manufacturing of high-throughput gene sequencing machines and related technologies. The company provides core tools for life science research, including genetic sequencers, laboratory automation systems, and robotic ultrasound systems.
Their primary market includes academic institutions, pharmaceutical companies, and clinical laboratories. MGI Tech's business model is centered on the sale of these instruments and the associated reagents and consumables required for their operation. A key technology is their proprietary DNBSEQ™, which is designed to improve the efficiency and productivity of sequencing. The company also offers solutions for pathogen detection and single-cell omics, expanding its reach into public health and specialized research areas. By providing a range of products from library preparation kits to large-scale sequencing platforms, MGI Tech serves a broad spectrum of the genomics market.
Keywords: gene sequencing, life sciences, genomics, multi-omics, laboratory automation, DNBSEQ, reagents, consumables, pathogen detection, single-cell omics